The Canadian Centre for Applied Research in Cancer Control

Abstract submission for #ARCC2025 @ CCRC2025 is NOW OPEN!

/0 Comments/in /by
As a reminder, #ARCC2025 is officially a part of the 2025 Canadian Cancer Research Conference. Abstracts are now being accepted for this important event which is being held in Calgary on November 2-4, 2025. Find out more at https://cc-arcc.ca/arcc-conference-2025/ and https://www.ccra-acrc.ca/conference/ The conference will feature plenary, concurrent, and lightning sessions, (more…)
Canadian Partnership Against Cancer logo

CPAC – Lead, Forecasting and Modelling

/0 Comments/in , /by
The Lead, Forecasting and Modelling supports the Cancer Systems and Innovation Division in carrying out projects and initiatives to achieve the Partnership’s overall vision to reduce the burden of cancer on all people in Canada. Reporting to the Manager, Decision Support, and working closely with key experts, the incumbent provides content-specific expertise (more…)

Ontario Cancer Statistics 2024

/0 Comments/in , /by
Ontario Cancer Statistics 2024 is now available. It is the fifth in a series of reports that provide comprehensive information on the burden of cancer in the province. This edition continues to provide a snapshot of the burden of childhood cancers (ages 0 to 14) through the contribution of the Pediatric (more…)

TFRI’s Digital Health & Discovery Platform’s Digital Health Innovation Fund

/0 Comments/in , /by
The DHDP is launching a Request for Applications for the Digital Health Innovation Fund. The purpose of this opportunity is to support the development of research programs through their use of the Platform. While the fund prioritizes oncology and neurology research programs, the DHDP is a disease agnostic initiative. Applications (more…)

UofT RWE Bootcamp – Registration is open

/0 Comments/in , /by
Course Overview For full details and to register please visit https://www.pharmacy.utoronto.ca/programs/continuing-professional-development/RWE-Bootcamp  Explore Real World Evidence (RWE) in a 3-day program designed by experts and tailored for professionals seeking to enter or enhance their knowledge in this field. This program is set at a beginner or novice level. We will cover (more…)

Registration for CAHSPR 2025 is now open!

/0 Comments/in , /by
The 2025 CAHSPR Conference is being held from May 26-29, 2025 in Ottawa at the Delta Hotel. The 2025 conference theme is “Charting the Course for Health System Transformation”.  As the Cancer Theme Group for CAHSPR, ARCC will be hosting a specialized session at CAHSPR2025 discussing the use of Synthetic (more…)

2025 CCRA Patient Involvement in Cancer Research Program (PIP)

/0 Comments/in , /by
CCRA’s Patient Involvement in Cancer Research Program (known as PIP) will be offered this year as an in-person program. PIP is interwoven with the Canadian Cancer Research Conference (CCRC) and provides participants with an opportunity to learn about leading edge science and network with cancer researchers and trainees. Patients will be (more…)

CPAC – Specialist, Forecasting and Modelling

/0 Comments/in , /by
Closing Date: March 9, 2025 Job Type: Permanent; 2 vacancies Job Level: Level 6 salary range: $80,624 – $109,080 per year; Compensation offered will be based on an assessment of the candidate’s knowledge, skills, competencies, and experience, while ensuring internal equity. Location: Hybrid; CPAC’s head office is in Toronto, Ontario. Candidates (more…)

2025 CCTG Recognition Awards

/0 Comments/in , /by
The Canadian Cancer Trials Group is seeking nominations for the 2025 Recognition Awards honouring individuals who have contributed significantly to the mission and activities of the Group. CCTG is seeking nominations for the following Recognition Awards: Founder’s Award: Dr. Joseph Pater Excellence in Clinical Trials Research The Founder’s Award is (more…)

CDA – Consultation on Proposed Improvements to the Reimbursement Review Process

/0 Comments/in , /by
Please visit https://www.cda-amc.ca/consultation-proposed-improvements-reimbursement-review-process for full information on this opportunity. The drug Reimbursement Review process at Canada’s Drug Agency plays a critical role in the pathway that helps patients access new drugs. In June 2023, CDA signalled program improvements that could be explored or added to the process. Since that time, (more…)